Aikawa Yoshiyuki 4

What Happened
Aikawa Yoshiyuki, reported as a 10% owner of SBC Medical Group Holdings, sold 465,000 shares of SBC on April 28, 2026. The Form 4 lists the transaction price as $3.02 per share (total reported proceeds $1,405,463); a footnote clarifies the net price received was $3.0225 per share. This was a sale (not a purchase) and was executed pursuant to the underwriters' option related to an underwritten public offering that initially closed April 21, 2026.

Key Details

• Transaction date: April 28, 2026. Report filed April 29, 2026 (filed within the usual Form 4 window).
• Reported sale: 465,000 shares at $3.02/share (net price $3.0225/share per footnote); proceeds ≈ $1,405,463.
• Shares owned after transaction: not explicitly stated in the filing.
• Footnote highlights:
  • F1: Sale executed under the underwriters' option; $3.0225 is net price received.
  • F2: The filing reports 861,600 SBC shares indirectly beneficially owned via Aikawa Equity Management Co., Ltd. (AEM) based on the Reporting Person’s 8,616 AEM shares × 100 SBC shares each; the Reporting Person disclaims control of AEM.
  • F3: Indicates additional SBC shares are held by Aikawa Investment Co., Ltd., a company wholly owned by the Reporting Person (quantity not specified).
• No late filing flag was indicated.

Context
This sale was part of an offering-related transaction (underwriters' option), which is common when insiders or selling stockholders participate in underwriting arrangements. As a 10% owner, Aikawa is a significant holder but the filing notes he does not control AEM and disclaims beneficial ownership of AEM-held shares except for his pecuniary interest. The filing is factual — it shows a disposal of shares but does not state any motive or trading strategy.